SG11202109160UA - Reducing intersample analyte variability in complex biological matrices - Google Patents
Reducing intersample analyte variability in complex biological matricesInfo
- Publication number
- SG11202109160UA SG11202109160UA SG11202109160UA SG11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA
- Authority
- SG
- Singapore
- Prior art keywords
- intersample
- reducing
- complex biological
- biological matrices
- analyte variability
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G01N15/01—
-
- G01N15/075—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962822349P | 2019-03-22 | 2019-03-22 | |
| PCT/US2020/023866 WO2020198011A1 (en) | 2019-03-22 | 2020-03-20 | Reducing intersample analyte variability in complex biological matrices |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202109160UA true SG11202109160UA (en) | 2021-10-28 |
Family
ID=70228886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202109160U SG11202109160UA (en) | 2019-03-22 | 2020-03-20 | Reducing intersample analyte variability in complex biological matrices |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220178940A1 (en) |
| EP (1) | EP3942295A1 (en) |
| JP (1) | JP2022524975A (en) |
| KR (1) | KR20210142694A (en) |
| CN (1) | CN113508297A (en) |
| AU (1) | AU2020245346A1 (en) |
| CA (1) | CA3134336A1 (en) |
| IL (1) | IL286495A (en) |
| SG (1) | SG11202109160UA (en) |
| WO (1) | WO2020198011A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021364335A1 (en) * | 2020-10-20 | 2023-06-22 | Definitek, Inc. | Quantification of previously undetectable quantities |
| CN112666356A (en) * | 2020-12-31 | 2021-04-16 | 国家纳米科学中心 | Method for detecting trace protein |
| CN116899626B (en) * | 2023-09-08 | 2023-12-26 | 北京青颜博识健康管理有限公司 | Catalytic system composition for click chemistry reaction, preparation method thereof and application thereof in biological detection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5475096A (en) | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
| US5719273A (en) | 1993-06-14 | 1998-02-17 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide |
| US5945527A (en) | 1996-05-30 | 1999-08-31 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
| US6242246B1 (en) | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
| US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
| US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| KR101842269B1 (en) | 2010-04-12 | 2018-03-26 | 소마로직, 인크. | 5-position modified pyrimidines and their use |
-
2020
- 2020-03-20 WO PCT/US2020/023866 patent/WO2020198011A1/en active Application Filing
- 2020-03-20 CA CA3134336A patent/CA3134336A1/en active Pending
- 2020-03-20 KR KR1020217033765A patent/KR20210142694A/en unknown
- 2020-03-20 AU AU2020245346A patent/AU2020245346A1/en active Pending
- 2020-03-20 EP EP20718109.0A patent/EP3942295A1/en active Pending
- 2020-03-20 CN CN202080018439.0A patent/CN113508297A/en active Pending
- 2020-03-20 JP JP2021552175A patent/JP2022524975A/en active Pending
- 2020-03-20 SG SG11202109160U patent/SG11202109160UA/en unknown
- 2020-03-20 US US17/438,120 patent/US20220178940A1/en active Pending
-
2021
- 2021-09-19 IL IL286495A patent/IL286495A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022524975A (en) | 2022-05-11 |
| US20220178940A1 (en) | 2022-06-09 |
| CA3134336A1 (en) | 2020-10-01 |
| EP3942295A1 (en) | 2022-01-26 |
| AU2020245346A1 (en) | 2021-09-09 |
| WO2020198011A1 (en) | 2020-10-01 |
| KR20210142694A (en) | 2021-11-25 |
| IL286495A (en) | 2021-10-31 |
| CN113508297A (en) | 2021-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286495A (en) | Reducing intersample analyte variability in complex biological matrices | |
| EP3371194A4 (en) | Protein sequencing methods and reagents | |
| EP3735481A4 (en) | Methods for fabricating high resolution dna array and its application in sequencing | |
| HK1254396A1 (en) | Method and kit for dna fragment assembling in vitro | |
| IL287318A (en) | Materials and methods for protein production | |
| EP3674419A4 (en) | Probe and method applying the same for enriching target region in high-throughput sequencing | |
| IL278022A (en) | Microfluidic method for single cell analysis | |
| IL279921B1 (en) | System and method for evaluating and determining color in gemstones | |
| SG11202010543QA (en) | Yeast proteins | |
| EP3880151A4 (en) | Determining treatment response in single cells | |
| EP3517966A4 (en) | Reagent composition for measuring glycated hemoglobin and method for measuring glycated hemoglobin using same | |
| EP3408770A4 (en) | Pessimism reduction in static timing analysis | |
| IL288014A (en) | Controlling intersample analyte variability in complex biological matrices | |
| IL281796A (en) | Antibody quantification in biological samples | |
| EP3286160A4 (en) | PROCESS FOR REDUCING 1233xf CONCENTRATION IN 244bb | |
| DK3536805T3 (en) | Analytical methods and arrays for use in the same | |
| EP3527669A4 (en) | Kit for hemoglobin a1c quantitative analysis | |
| GB201913908D0 (en) | Improvements in interaction analysis | |
| GB2579810B (en) | Assay Analysis | |
| EP3610012A4 (en) | High-throughput absorbance measurements of samples in microcapillary arrays | |
| IL278937A (en) | Hsp70 protein levels in pbmc samples as biomarker for disease | |
| EP3814500A4 (en) | Methods for analyzing dna in urine | |
| GB201710524D0 (en) | Controlling intersample analyte variability in complex biological matrices | |
| ZA202106718B (en) | Novel selection marker-comprising cell line and uses thereof for protein production | |
| DK3615689T3 (en) | Analytical methods and arrays for use in the same |